INGN Inogen, Inc

$5.31▲ +2.51% Healthcare Other
After hours $5.31▲ +0.00% Sep 11, 7:30 PM ET
Volume 249.0K Avg Volume (10D) 245.4K
Key Metrics & Fundamentals
Market Cap
$140.92M
P/E Ratio
–
Div Yield
–%
52W Range
5.16 - 9.13
% vs 50 MA
-11.94%
% vs 200 MA
-16.59%
RSI-14
36.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.55
Free Cash Flow
$1.03M
Gross Rev
$95.08M
Gross Profit
$43.27M
EBITDA
-$399,000
COGS
$51.81M
Operating Exp
$48.37M
Operating Income
-$5.10M
EBIT
-$5.10M
Pretax Income
-$4.00M
Net Income
-$3.85M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Zacks · Aug 21, 2026 3:46 PM
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
Zacks · Aug 19, 2026 2:08 PM
Inogen (INGN) Cuts Guidance Even As Profitability Climbs
Insider Monkey · Aug 17, 2026 7:36 PM
Inogen (INGN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 3:03 PM
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists
Zacks · Aug 11, 2026 4:23 PM
Should Investors Buy Inogen as Low Valuation Meets Execution Risk?
Zacks · Aug 11, 2026 4:22 PM
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
Zacks · Aug 10, 2026 4:54 PM
Inogen, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong International Growth and New ...
GuruFocus.com · Aug 7, 2026 5:04 AM
Inogen Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 3:03 AM
Financial Overview - Income Statement Quarterly

See INGN's money flow as a full page

Social Sentiment
Avg +0.80 · 4 posts
DDTrade$INGN is trading 0.18x enterprise value to revenue with no debt
r/stocks · Jul 27, 2026
The author presents a bullish argument based on strong fundamentals and undervaluation of INGN, suggesting significant upside potential.
positive +0.70
DDDiscussionPriceTargetPortable Oxygen Company with 60% of Market Cap in Cash(No debt) $INGN
r/investing · Jul 24, 2026
The post highlights several bullish factors for INGN: strong cash position, low valuation (0.18x sales), growth prospects, and a favorable industry landscape.
very_positive +0.90
DDportable oxygen company trades at a $64M enterprise value on $351M of trailing revenue. Full thesis below $INGN
r/investing · Jul 23, 2026
The post highlights positive aspects of the company's valuation and strategy (debt-free, cash-rich, etc.) with a bullish assessment.
positive +0.80
NewsDiscussionTradeInogen (INGN) starting to grow again?
r/stocks · Apr 25, 2026
The post highlights positive developments like hiring, new product launches, and a strong balance sheet, leading to a bullish outlook.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙